Valtronic Technologies (USA) is proud to welcome Mike Labbe in the newly created position of Director R&D. This key position will lead the continued strategic buildup of R&D capabilities at Valtronic U.S. With over 25 years’ experience in the medical device industry, Mike will drive the site’s expansion of R&D capabilities. Valtronic’s U.S. General Manager Jay Wimer said, “Mike brings new focus to our R&D activities in the U.S. We’re excited about what it means for our future to have someone with his capabilities and qualifications as part of our team.”
Mike’s background and experience make him the ideal candidate for this key position. He has a Master of Science degree in Biomedical Engineering from Case Western Reserve University in Cleveland, OH and a Bachelor of Science in Electrical Engineering from Worcester Polytechnic Institute in Worcester, MA. Prior to joining Valtronic, Mike served as Director of New Product Development at Neurotechnology Innovations Translator (NIT), as Director of R&D at Greatbatch’s QIG Group/Nuvectra, and as Vice President Engineering at BIOMEC. Mike has led the development of numerous Class II and IIII medical device projects from concept through regulatory approval, most recently for a Class III fully implantable SCS neurostimulation system for the treatment of chronic pain. He holds seven U.S. patents, has been published in Medical Physics, and has been a presenter at the American Association of Physicists in Medicine.
Mike’s focus is to create a strong R&D team in the U.S. comparable to that of Valtronic’s global headquarters in Switzerland. “Developing similar R&D capabilities in Solon will be a strong asset for Valtronic”, adds Rainer Platz, CEO. “Offering our customers the full range of solutions, from design and feasibility, to development, industrialization and manufacturing is key to allow for high quality innovative medical devices. With Mike’s experience in the medical device field, and his understanding of the customer’s and patients’ needs, the way is paved for even more innovative breakthroughs.”